AI Startups

    Generare raises $23.2M to discover unknown molecules and advance new drugs

    Generare Bioscience SAS, a Paris-based biotechnology company generating never-before-seen molecular data for drug development using artificial intelligence, announced today it has raised €20 million, about $23.3 million, in an early-stage funding round co-led by Alven and Daphni....

    S

    SiliconANGLE

    Source

    Generare raises $23.2M to discover unknown molecules and advance new drugs
    AI Analysis

    Generated insight by OnAirToday AI

    Generare leverages AI to create novel molecular data, accelerating the identification of new drug candidates. This significant funding highlights investor confidence in AI's transformative potential within pharmaceutical research and development.

    Powered by AI • Not a substitute for human analysisMore Insights →
    Read the full story at SiliconANGLE →
    Share
    Filed under:AI Startups

    Comments

    Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.

    0/1000